Navigation Links
ImaRx Provides Update on TUCSON Phase I/II Clinical Trial in Acute Ischemic Stroke
Date:1/4/2008

TUCSON, Ariz., Jan. 4 /PRNewswire-FirstCall/ -- ImaRx Therapeutics, Inc. (Nasdaq: IMRX) today provided an update on its TUCSON (Transcranial Ultrasound in Clinical SONolysis) clinical trial in patients with acute ischemic stroke.

TUCSON Study Overview

The TUCSON trial is a Phase I/II randomized, placebo controlled clinical trial. This trial is designed to evaluate the safety, tolerability and activity of four escalating doses of MRX-801 microbubbles and ultrasound as an adjunctive therapy to tissue plasminogen activator (tPA) treatment in subjects with acute ischemic stroke. The trial design includes four dose cohorts of 18 subjects each randomized to receive either treatment (MRX-801, ultrasound and tPA) or control (tPA alone). Safety is assessed by the incidence of symptomatic intracranial hemorrhage (sICH) within 36 hours following the initiation of treatment. Activity is assessed by recanalization, defined as increased blood flow in the occluded artery, which is viewed by clinicians as a key factor in improving the probability of complete clinical recovery. Improvements in functional and neurological outcomes are measured by improvement in NIHSS and Modified Rankin scores, widely accepted instruments used to assess clinical outcomes for stroke. To date, the Company has completed enrollment of all 18 subjects in Cohort 1 (12 treated and 6 control) and 17 subjects in Cohort 2 (11 treated and 6 control).

TUCSON Preliminary Results

Cohort 1

Cohort 1 evaluated one vial of MRX-801. There were no unexpected safety events and there were signs of improved recanalization in treated patients compared to controls. In clinical recovery endpoints, the number and proportion of patients who experienced dramatic or e
'/>"/>

SOURCE ImaRx Therapeutics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Progen Provides Update on Phase 3 Clinical Program for PI-88 in Liver Cancer
2. IDM Pharma Provides Update of Product Pipeline and Announces Plans to Evaluate Strategic Alternatives for the Company
3. NicOx Completes Enrollment in Second Pivotal Phase 3 Study for Naproxcinod and Provides Development Update
4. Radiesse Provides Greater Patient Satisfaction Than Either Juvederm or Perlane as Reported in a 205-Patient Clinical Trial Published in the Journal of Dermatologic Surgery
5. Replidyne Provides Strategic Update
6. BioCryst Provides Forodesine HCl Update
7. Celtic Pharma Provides Update on XERECEPT(R) Clinical Program
8. Poniard Pharmaceuticals Provides Year-End Clinical Update at 2007 Lazard Capital Markets Healthcare Conference
9. Sinovac Provides Update in Pandemic Influenza Vaccines (H5N1) Phase II Clinical Trials
10. Isis Reports New Data for Mipomersen in Routine High Cholesterol Patients and Provides Cumulative Safety Summary
11. Improved Cornea Surgery Technique Provides Enhanced Transplant Success
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... , July 30, 2015 ... new research report with market overview, trends, ... forecast, porter analysis, recent developments, competitive scenario ... Global Industry Insight: Biosensors Market Development and ... (Logo: http://photos.prnewswire.com/prnh/20150727/756778 ) Explore ...
(Date:7/30/2015)... , July 30, 2015 Takeda Pharmaceutical ... study to fulfill the post-marketing commitment and submissions ... Pan European Multi-Database Bladder Cancer Risk Characterization Study ... cohort study, conducted in four European countries, for ... up to 10 years of follow-up. Findings demonstrate ...
(Date:7/30/2015)... 30, 2015 Vermillion, Inc. (VRML), ... disease, announced today it will report its ... market close on Thursday, August 13, 2015, ... webcast at 4:30pm Eastern.Conference Call and Webcast:  ... Eastern/1:30pm Pacific  Domestic: , 888-430-8691International: ...
Breaking Medicine Technology:Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 2Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 3Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 4Global Biosensors Market (Size of $12,964 Million in 2014) to Witness 10% CAGR During 2015 - 2020 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 2Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 3Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 4Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 5Takeda Announces Completion of the Pioglitazone Post-Marketing Commitment and Submission of Results to the EMA, the FDA and the PMDA 6
... address to a conference on Regional Innovation Clusters today, ... Eli Lilly and Company (NYSE: LLY ), ... innovation as a key to renewing the nation,s economy. ... of the Obama administration, at a conference co-hosted by ...
... that a new market research report is available in ... PharmaVitae Profile http://www.reportlinker.com/p0201761/Eli-Lilly--Co-PharmaVitae-Profile.html ... and forecast performance for Eli Lilly in the prescription ... and pipeline analysis and assessment of financial per ...
Cached Medicine Technology:Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 2Lilly CEO Says Regional Innovation Clusters Can Renew the Nation's Economy 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 2Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 3Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 4Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 5Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 6Reportlinker Adds Eli Lilly & Co.: PharmaVitae Profile 7
(Date:7/30/2015)... ... 30, 2015 , ... Well-known San Diego AC, plumbing and ... cost service and repair companies. For 35 years, they have grown both their ... to meet the demands of the changing technological environment. , To ...
(Date:7/30/2015)... ... July 30, 2015 , ... The need for accessibility ... effort to provide comfort to patients as well as visiting friends and family during ... phone charging stations. , The stations - powered by ChargeItSpot , a Philadelphia-based ...
(Date:7/30/2015)... (PRWEB) , ... July 30, 2015 , ... ... of the ‘Mary Jo Lawyer-Spano Mesothelioma Patient Registry Act of 2015’. The ... (D-IL), Chris Collins (R-NY), Peter King (R-NY), Betty McCollum (D-MN), Joe Kennedy (D-MA), ...
(Date:7/30/2015)... ... July 30, 2015 , ... On July 23rd Clay Today Online ... to fund the state’s large prison system, which has amassed largely enough throughout the ... incarceration. In light of President Obama’s recent reduction of non violent drug offender’s prison ...
(Date:7/30/2015)... ... July 30, 2015 , ... The American Association ... Rosenberg’s announcement of the reinstitution of National Prescription Drug Take-Back Days. The 10th ... 10:00 AM to 2:00 PM local time. On the 26th, the DEA, with ...
Breaking Medicine News(10 mins):Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 2Health News:Bill Howe Plumbing, Heating & Air Launches Online Application to Prospective Employees 3Health News:Hospitals Add Phone Charging Stations as an Amenity for Patients and Visitors 2Health News:Bill to Create Patient Registry for Deadly Cancer Introduced in Congress 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 2Health News:Florida Questions Its Spending on Punitive Incarceration in Light of Exorbitant Costs for Non Violent Offenders 3Health News:AAPCC Supports National Prescription Drug Take-Back Day 2Health News:AAPCC Supports National Prescription Drug Take-Back Day 3
... COVER: "Growing Up Bipolar" (p. 32). General Editor Mary ... have been diagnosed as,bipolar, no doubt some of them ... it,s unclear how they work, and, often, they don,t ... effects in children. Yet,untreated bipolar disorder can be disastrous; ...
... microscope at end of endoscope allows immediate imagery of ... A real-time microscopic technique called confocal laser endomicroscopy (CLE) ... disorders such as cancer, reflux disease, and inflammatory bowel ... be presented May 18 at the Digestive Disease Week ...
... Scientists have developed the first genetically altered monkey model ... disease, according to a new study funded by the ... better understand this complex, devastating and incurable genetic disorder ... 18 advance of online publication edition of Nature, could ...
... Tons of Emergency Medicines and Medical Supplies Arrives in ... ... Conn., May 18 The government of Myanmar today,cleared for entry ... AmeriCares - a nonprofit international aid,organization. The relief package will be ...
... marker found in cord blood of stressed mothers, babies , ... expectant mother is exposed to high levels of stress, her ... later in life, new research suggests. , Babies born to ... their blood at birth than did babies born to less-stressed ...
... ATS 2008, TORONTOWhen men present in emergency departments with ... and have a greater risk of dying over the ... receive, according to research from the University of Pittsburgh ... 2008 International Conference in Toronto on Tuesday, May 20. ...
Cached Medicine News:Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 2Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 3Health News:NEWSWEEK: Media Lead Sheet/May 26, 2008 Issue (on newsstands Monday, May 19, 2008) 4Health News:New Technology Speeds GI Disease Diagnosis 2Health News:New Technology Speeds GI Disease Diagnosis 3Health News:Researchers develop first transgenic monkey model of Huntington's disease 2Health News:AmeriCares Delivers Life-Saving Aid to Myanmar 2Health News:Mom's Stress in Pregnancy May Up Baby's Asthma and Allergy Risk 2Health News:Mom's Stress in Pregnancy May Up Baby's Asthma and Allergy Risk 3Health News:Gender disparity in community-acquired pneumonia 2
The PalmSAT® 2500 series are small, yet versatile digital pulse oximeters for accurate assessment of blood oxygen saturation and pulse rate. Choose alarm or non-alarm versions for your portable ...
... The WristOx® 3100 is ... designed to be worn comfortably ... for monitoring daily activities and ... design of the WristOx is ...
The Dolphin Voyager is a pulse oximetry engine designed in the standard Compact Flash format. This card slides into any Compact Flash socket and, with the accompanying Dolphin ONE software, provides ...
... the worlds first spot check monitor ... rate to use reflectance pulse oximetry ... Medicals patented technology to provide a ... for many patients and less expensive ...
Medicine Products: